OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Cardiovascular Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
List of recent issues	163
From the editor's desk-overweight and obesity and obesity paradox in cardiovascular diseases	128
Emerging topics in electrophysiology	120
Table of contents	65
Cover 2 (Masthead)	65
Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era	54
Chronic thrombosis of bioprostheses: Diagnosis and management	46
Cover 2 (Masthead)	44
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study	42
List of recent issues	41
Table of contents	40
Cover 2 (Masthead)	40
Cover 2 (Masthead)	39
Cover 2 (Masthead)	39
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?	35
Table of contents	33
Estrogen and cardiovascular disease	33
Multimodality imaging of hypertrophic cardiomyopathy	33
Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials	33
Use of mechanical circulatory support in high-risk percutaneous coronary interventions	33
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis	32
Supervised exercise therapy for patients with peripheral artery disease: Clinical update and pathways forward	32
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy	32
Updates on obesity and the obesity paradox in cardiovascular diseases	32
Normative values for body composition in 22,191 healthy Norwegian adults 20–99 years: The HUNT4 study	31

Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio	30
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID – Best practice approaches	29
Cover 2 (Masthead)	29
Evidence to support health system prioritization of health behaviors in the COVID-19 era	29
The weekly mortality for ischemic heart disease in the US still peaks on mondays	28
List of recent issues	28
Editorial Board	27
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus	27
Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing	26
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know	26
Cardiac rehabilitation 2022	23
Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a “cholesterol paradox?”	23
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation	23
Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study	23
Table of contents	22
Incidence of acute myocardial infarction and hurricane Katrina: Fourteen years after the storm	22
Editorial Board	22
Impact of age on the utility of CardioMEMS device in reducing heart failure readmissions	22
Antegrade techniques for chronic total occlusion percutaneous coronary intervention	21
Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword	21
Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men	21
The polypill strategy in cardiovascular disease prevention: It's time for its implementation	21
The connection between sleep deficiency and coronary artery disease: Complexities and controversies	21
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease	21
Beyond cardioversion, ablation and pharmacotherapies: Risk factors, lifestyle change and behavioral counseling strategies in the prevention and treatment of atrial fibrillation	20
Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment	20
Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies	19
HCM's hidden cost: The impact of socioeconomic status	19
Reflections on community experience with Mavacamten	19
Multimodality imaging for prosthetic valves evaluation: Current understanding and future directions	19
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Exam	19
Leisure time versus occupational physical activity for cardiometabolic risk	19
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction	18
Unmet needs and future directions in hypertrophic cardiomyopathy	18
Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management	18
Of meat & molecules	18
Social justice equity in healthy living medicine - An international perspective	17
Leadless pacemakers: A review of current data and future directions	17
Prognostic value of troponin I in atrial fibrillation	17
Exercise and cardiovascular health: A state-of-the-art review	17
Prosthesis-patient mismatch following aortic and mitral valves replacement – A comprehensive review	17
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigation	16
Adipo-cardiology: The next frontier in cardiovascular disease	16
The culture of healthy living – Exploring the chaos that drives health behaviors	16
Predicting life expectancy in the United States: The importance of healthy living behaviors and residential geography	16
Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants	16
Debunking the vegan myth: The case for a plant-forward omnivorous whole-foods diet	16
Dose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States	16
Table of contents	16
Cover 2 (Masthead)	15

The physiologic benefits of optimizing cardiorespiratory fitness and physical activity – From the cell to systems level in a post-pandemic world	15
Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary A	15
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)	15
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States	15
Recognizing risk factors associated with poor outcomes among patients with COVID-19	15
Editorial Board	15
A successful home-based cardiac rehabilitation program in the early phase of the COVID-19 pandemic	15
Popular fad diets: An evidence-based perspective	14
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin	14
Effect of BMI on patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis	14
Systems science approaches to cardiovascular disease prevention and management in the era of COVID-19: A Humpty-Dumpty dilemma?	14
Temporary mechanical circulatory support in cardiogenic shock	14
Optical coherence tomography angiography in cardiovascular disease	14
Exercise blood pressure, cardiorespiratory fitness and mortality risk	13
Health equity in heart failure	13
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy	13
Nine Years as Editor-in Chief of Progress in Cardiovascular Diseases	13
Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan	12
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study	12
Enhancing participation in cardiac rehabilitation: Focus on underserved populations	12
Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia	12
Can the outlier percentiles from norms increase the sensitivity of the ECG criteria for screening athletes?	12
Prioritizing the primary prevention of heart failure: Measuring, modifying and monitoring risk	12
Social determinants of health, health disparities, and adiposity	12
The obesity wars and the education of a researcher: A personal account	12
COVID-19, Unhealthy lifestyle behaviors and chronic disease in the United States: Mapping the social injustice overlay	12
Cardiorespiratory fitness and physical activity in the lens of social justice – Reporting on the disparities that exist	12
Mitral valve diseases: Pathophysiology and interventions	11
List of recent issues	11
Statin associated muscle symptoms: An update and review	11
Peak oxygen pulse and mortality risk in healthy women and men: The Ball State Adult Fitness Longitudinal Lifestyle Study (BALL ST)	11
Progress in Cardiovascular Diseases Statistics 2022	11
Association of neighborhood median income to outcomes in hypertrophic cardiomyopathy	11
Editorial Board	11
Building a culture of healthy living in the workplace	11
Editor handoff PCVD	11
Tricuspid valve replacement: The old and the new	11
Dietary dilemmas	11
Clinical conundrums involving statin drug-drug interactions	10
Recommendations on the use of artificial intelligence in health promotion	10
Catheter based interventions for lower extremity peripheral artery disease	10
A review of the interplay between Takotsubo cardiomyopathy and adrenal insufficiency: Catecholamine surge and glucocorticoid deficiency	10
Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective	10
The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease	10
Social justice as it relates to healthy living behaviors and medicine: The current state of inequity and the path forward	10
A culture of health promotion in healthcare: Can't pour from an empty cup	9
Cover 2 (Masthead)	9
Assessing cardiorespiratory fitness in clinical and community settings: Lessons and advancements in the 100th year anniversary of VO2max	9
Exercise as a therapeutic modality for the prevention and treatment of depression	9
Insight into different phenotypic presentations of heart failure with preserved ejection fraction	9
Editorial Board	9
Complications of percutaneous coronary intervention	9
High-power, short-duration ablation for atrial fibrillation: Pros and cons	9
Table of contents	9
Role of multimodality imaging in infective endocarditis: Contemporary diagnostic and prognostic considerations	9
Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings	9